Protein Science Attend a BioResearch Product Faire
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print April 5, 2006, 10.1110/ps.052030506
Protein Science (2006), 15:949-960. Published by Cold Spring Harbor Laboratory Press. Copyright © 2006 The Protein Society
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Research Data
Right arrow All Versions of this Article:
ps.052030506v1
15/5/949    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clark, L. A.
Right arrow Articles by Van Vlijmen, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clark, L. A.
Right arrow Articles by Van Vlijmen, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Affinity enhancement of an in vivo matured therapeutic antibody using structure-based computational design

Louis A. Clark, P. Ann Boriack-Sjodin, John Eldredge, Christopher Fitch, Bethany Friedman, Karl J.M. Hanf, Matthew Jarpe, Stefano F. Liparoto, You Li, Alexey Lugovskoy, Stephan Miller, Mia Rushe, Woody Sherman, Kenneth Simon and Herman Van Vlijmen

Biogen Idec, Inc., Cambridge, Massachusetts 02142, USA

(RECEIVED December 12, 2005; FINAL REVISION February 13, 2006; ACCEPTED February 16, 2006)

Improving the affinity of a high-affinity protein–protein interaction is a challenging problem that has practical applications in the development of therapeutic biomolecules. We used a combination of structure-based computational methods to optimize the binding affinity of an antibody fragment to the I-domain of the integrin VLA1. Despite the already high affinity of the antibody (Kd ~7 nM) and the moderate resolution (2.8 Å) of the starting crystal structure, the affinity was increased by an order of magnitude primarily through a decrease in the dissociation rate. We determined the crystal structure of a high-affinity quadruple mutant complex at 2.2 Å. The structure shows that the design makes the predicted contacts. Structural evidence and mutagenesis experiments that probe a hydrogen bond network illustrate the importance of satisfying hydrogen bonding requirements while seeking higher-affinity mutations. The large and diverse set of interface mutations allowed refinement of the mutant binding affinity prediction protocol and improvement of the single-mutant success rate. Our results indicate that structure-based computational design can be successfully applied to further improve the binding of high-affinity antibodies.

Keywords: antibody; affinity maturation; computational protein design; protein–protein interactions; binding energy prediction



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Barderas, J. Desmet, P. Timmerman, R. Meloen, and J. I. Casal
Affinity maturation of antibodies assisted by in silico modeling
PNAS, July 1, 2008; 105(26): 9029 - 9034.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. S. E. Lengyel, L. J. Willis, P. Mann, D. Baker, T. Kortemme, R. K. Strong, and B. J. McFarland
Mutations Designed to Destabilize the Receptor-Bound Conformation Increase MICA-NKG2D Association Rate and Affinity
J. Biol. Chem., October 19, 2007; 282(42): 30658 - 30666.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. S. Gardberg, L. T. Dice, S. Ou, R. L. Rich, E. Helmbrecht, J. Ko, R. Wetzel, D. G. Myszka, P. H. Patterson, and C. Dealwis
Molecular basis for passive immunotherapy of Alzheimer's disease
PNAS, October 2, 2007; 104(40): 15659 - 15664.
[Abstract] [Full Text] [PDF]


Home page
Protein Eng Des SelHome page
M. K. DiTursi, S.-J. Kwon, P. J. Reeder, and J. S. Dordick
Bioinformatics-driven, rational engineering of protein thermostability
Protein Eng. Des. Sel., November 1, 2006; 19(11): 517 - 524.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. A. Clark, S. Ganesan, S. Papp, and H. W. T. van Vlijmen
Trends in Antibody Sequence Changes during the Somatic Hypermutation Process
J. Immunol., July 1, 2006; 177(1): 333 - 340.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by The Protein Society.